开窗支架腔内修复术后肾上主动脉颈扩张的量化研究
本研究为单中心回顾性分析,纳入43例接受Cook ZFEN开窗支架治疗的近肾动脉瘤患者,量化术后肾上主动脉颈扩张。中位随访30.3个月,74.4%患者出现扩张,第一密封支架中部年均增长0.99 mm;过度oversizing预测扩张,而较长近端密封长度具有保护作用。
要点
- FEVAR术后肾上主动脉扩张常见,中期随访发生率达74.4%。
- 装置oversizing每增加10%,颈扩张增加1.34 mm;密封长度每增加10 mm,扩张减少1.82 mm。
- 近端密封长度≥3 cm者扩张程度低于<3 cm者。
核心结论
- FEVAR术后肾上主动脉扩张常见,且与近端内漏无关;积极oversizing预测扩张,较长密封长度与较少扩张相关。
研究设计与样本
- 单中心回顾性研究,纳入2012至2018年接受Cook ZFEN治疗的近肾动脉瘤患者43例,共119根目标血管,平均随访30.3个月。
主要发现
- 任何位置主动脉颈扩张(≥3 mm)发生于32例(74.4%)患者。
- 从固定支顶端至第二密封支架中部所有测量点均见直径扩张。
- 第一密封支架中部扩张最显著,平均3.6 ± 3.2 mm,年增长0.99 mm(95%CI 0.7-1.28 mm)。
- oversizing每增加10%,颈扩张增加1.34 mm(P = .02);密封长度每增加10 mm,扩张减少1.82 mm(P = .016)。
- 近端密封长度≥3 cm者扩张2.6 mm,<3 cm者4.9 mm(P = .022);IA型内漏仅1例,与扩张无关(P = .256)。
关键数值与推荐
- 主动脉颈扩张定义为任一测量位置≥3 mm。
- 测量7个位置,以术后1个月内首次CT为基线,年度随访比较。
临床怎么用
- 支持FEVAR继续用于近肾动脉瘤,尤其能获得≥3 cm健康密封长度的患者。
- 应避免过度oversizing,并争取较长近端密封长度以减少颈扩张。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Suprarenal aortic neck dilation (AND) after fenestrated endovascular aneurysm repair (FEVAR) with commercially available devices has not yet been well characterized. The aim of this study was to measure diameter changes in the supravisceral aorta after FEVAR. METHODS: This is a single-center retrospective review involving patients with juxtarenal aneurysms treated with Cook ZFEN devices (Cook Medical, Bloomington, Ind). Patients with at least 1 year of cross-sectional radiologic follow-up were included. AND was defined as ≥3 mm at any measured location. Aortic diameter, defined as the average outer to outer diameter on three-dimensional centerline imaging, was measured at seven locations along the length of the ZFEN device from the proximal fixation struts to the bottom of the second seal stent. The first postoperative CT scan (≤1 month) served as a baseline from which subsequent measurements at annual intervals were compared. RESULTS: A total of 43 patients who underwent FEVAR from 2012 to 2018 met inclusion criteria, with a total of 119 target vessels (83 renal stents, 41 superior mesenteric artery scallops or large fenestrations). Mean follow-up time was 30.3 months. Any AND was found to occur in 32 (74.4%) patients. Aortic diameter dilation at latest follow-up was found to occur at all measured locations from the top of the fixation struts (1.9 ± 2.4 mm; P < .0001) to the middle of the second seal stent (1.3 ± 3.8 mm; P < .01). Diameter growth was most pronounced in the middle of the first seal stent, with mean AND of 3.6 ± 3.2 mm. At this location, the aorta experienced nearly linear annual growth of 0.99 mm (95% confidence interval, 0.7-1.28 mm) per year. Increasing device oversizing relative to the native visceral aorta was the strongest predictor of postoperative neck diameter growth (1.34 mm per 10% increase in oversizing; P = .02), whereas increasing proximal seal length was protective of growth (-1.82 mm per 10-mm increase in seal length; P = .016). Proximal seal lengths ≥3 cm were associated with less neck dilation compared with <3 cm (2.6 mm vs 4.9 mm; P = .022). Type IA endoleak in this cohort was rare (n = 1) and not associated with AND (P = .256). CONCLUSIONS: Dilation of the suprarenal aorta is a common finding in midterm follow-up after FEVAR and not associated with proximal endoleak. Aggressive device oversizing is predictive of dilation, whereas longer seal lengths are associated with less dilation along the suprarenal seal zone. These results support the continued use of FEVAR for juxtarenal aneurysms, particularly in patients in whom ≥3 cm of healthy seal length can be obtained.
引用
- Tran K, Deslarzes-Dubuis C, Lee JT, et al. Quantification of suprarenal aortic neck dilation after fenestrated endovascular aneurysm repair. J Vasc Surg. 2020. PMID: 32445831. doi:10.1016/j.jvs.2020.04.522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。